Author

M. Dharmasivam

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

D. R. Richardson· 2 shared Z. Kovacevic· 2 shared D. Graham· 1 shared D. Lanbe· 1 shared D.-H. Bae· 1 shared F. Shehadeh-Tout· 1 shared G. Babu· 1 shared H. H. Milioli· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. R. Richardson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Melanotransferrin Functions as a Pro-Oncogenic WNT Agonist: A Yin-Yang Relationship in Melanoma with the WNT Antagonist and Metastasis Suppressor, NDRG1

D. R. Richardson, J. Paluncic, M. Gholam Azad, D. Lanbe, J. Skoda, K. Park, S. Chiang, D.-H. Bae, R. Scolyer, R. Afroz, G. Babu, J. Wilmott, K. Loh, P. Jansson, M. Dharmasivam, , Z. Kovacevic

This study identifies MTf as a pro-oncogenic WNT agonist that forms a bidirectional feedback loop with NDRG1, promoting melanoma progression and metastasis.

bioRxiv · Feb 27, 2023 · PreprintCancer Biology

An Innovative Non-Hormonal Strategy Targeting Redox Active Metals to Down-Regulate Estrogen-, Progesterone-, Androgen- and Prolactin-Receptors in Breast Cancer

F. Shehadeh-Tout, H. H. Milioli, S. Roslan, P. J. Jansson, M. Dharmasivam, D. Graham, R. Anderson, T. Wijesinghe, M. G. Azad, D. R. Richardson, Z. Kovacevic

This paper investigates the effects of redox-active compounds Dp44mT and DpC on hormone receptors and resistance pathways in breast cancer, showing they suppress receptor expression and signaling through metal ion binding.

bioRxiv · Feb 2, 2023 · PreprintCancer Biology